FLGT
Fulgent Genetics Inc
NASDAQ: FLGT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.19
+2.64% today
Updated 2026-04-30
Market cap
$470.46M
P/E ratio
—
P/S ratio
1.46x
EPS (TTM)
$-1.97
Dividend yield
—
52W range
$13 – $31
Volume
0.7M
Fulgent Genetics Inc (FLGT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |